Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject
Status:
Completed
Trial end date:
2021-02-03
Target enrollment:
Participant gender:
Summary
The study was conducted to investigate whether 20 mg omeprazole capsules manufactured by PT.
Dankos Farma for PT. Hexpharm Jaya is bioequivalent to its reference product, 20 mg LosecĀ®
capsules manufactured by AstraZeneca AB, Sweden, imported by PT. AstraZeneca Indonesia.